During the progression of MASLD, persistent liver damage and TGF-β-driven fibrosis prompt macrophage infiltration, promoting tissue inflammation and the development of a proinflammatory precancerous microenvironment [27, 80]. Here, TGFB1 is linked to metabolic dysfunction-associated steatotic liver disease.